Nicholas Schorsch Purchases 8,000 Shares of American Strategic Investment (NYSE:NYC) Stock

American Strategic Investment Co. (NYSE:NYC) major shareholder Nicholas Schorsch bought 8,000 shares of American Strategic Investment stock in a transaction dated Tuesday, June 30th. The stock was purchased at an average price of $9.53 per share, with a total value of $76,240.00. Following the completion of the purchase, the insider owned 1,089,620 shares in the company, valued at $10,384,078.60. This trade represents a 0.74% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

American Strategic Investment Stock Performance

Shares of American Strategic Investment stock opened at $9.32 on Friday. The business has a 50-day simple moving average of $8.66 and a 200 day simple moving average of $8.70. American Strategic Investment Co. has a one year low of $7.00 and a one year high of $16.30. The company has a debt-to-equity ratio of 1.73, a current ratio of 0.03 and a quick ratio of 0.03. The firm has a market capitalization of $25.07 million, a price-to-earnings ratio of -1.10 and a beta of 0.19.

American Strategic Investment (NYSE:NYC) last announced its quarterly earnings results on Friday, May 15th. The company reported ($3.04) earnings per share (EPS) for the quarter. American Strategic Investment had a negative return on equity of 113.06% and a negative net margin of 53.18%.The firm had revenue of $7.35 million during the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of American Strategic Investment in a report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

About American Strategic Investment

American Strategic Investment Co (NYSE: NYC) owns a portfolio of high-quality commercial real estate located within the five boroughs of New York City.